siRNA Therapeutics in the Treatment of Diseases
Therapeutic Delivery2012Vol. 4(1), pp. 45–57
Citations Over TimeTop 13% of 2012 papers
Abstract
siRNAs are a class of dsRNAs, 21-23 nucleotides in length, which are able to silence their target genes through enzymatic cleavage of target mRNA. The sequence-specific gene-silencing by siRNA can be used as a new therapeutic approach for treatment of a variety of diseases that are incurable by conventional drugs. Many efforts have been made to overcome the problems related to delivery, stability, off-target gene silencing and immunostimulatory effects of siRNA. Different studies have carried out done to improve in vitro and in vivo delivery of naked or formulated siRNAs. In this review, different aspects of using siRNA as a new class of drugs will be discussed.
Related Papers
- → High potency silencing by single-stranded boranophosphate siRNA(2006)109 cited
- → Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference(2015)77 cited
- → Can siRNA Technology Provide the Tools for Gene Therapy of the Future?(2006)34 cited
- → Death without stress: The stiletto approach against disease(2004)3 cited
- Double-mismatched siRNAs enhance selective gene silencing of a mutant ALS-causing allele(2008)